New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study
Nonsteroidal aromatase inhibitors (NSAIs) are well-established drugs for the therapy of breast cancer. However, they display some serious side effects, and their efficacy can be compromised by the development of chemoresistance. Previously, we have reported different indazole-based carbamates and pi...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis Group
2021-01-01
|
| Collection: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Sujets: | |
| Accès en ligne: | http://dx.doi.org/10.1080/14756366.2021.1954918 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|